ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” third quarter 2022 investor letter. A copy of the same can be downloaded here.
US Bancorp DE lowered its position in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) by 4.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 42,359 shares of the biopharmaceutical company’s stock after selling 2,000 shares during the quarter. US […]
Citigroup Inc. decreased its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) by 4.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 114,657 shares of the biopharmaceutical company’s stock after selling 5,311 shares during the period. Citigroup Inc.’s […]